SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Michela Boi, Emanuele Zucca, Giorgio Inghirami, Francesco Bertoni, Advances in understanding the pathogenesis of systemic anaplastic large cell lymphomas, British Journal of Haematology, 2015, 168, 4
  2. 2
    Adam M. Petrich, Irene B. Helenowski, Locke J. Bryan, Shaina A. Rozell, Robert Galamaga, Chadi Nabhan, Factors predicting survival in peripheral T-cell lymphoma in the USA: a population-based analysis of 8802 patients in the modern era, British Journal of Haematology, 2015, 168, 4
  3. 3
    Ibrahim H. Younos, Fuminori Abe, James E. Talmadge, Myeloid-derived suppressor cells: their role in the pathophysiology of hematologic malignancies and potential as therapeutic targets, Leukemia & Lymphoma, 2015, 1

    CrossRef

  4. 4
    E. R. Parrilla Castellar, E. S. Jaffe, J. W. Said, S. H. Swerdlow, R. P. Ketterling, R. A. Knudson, J. S. Sidhu, E. D. Hsi, S. Karikehalli, L. Jiang, G. Vasmatzis, S. E. Gibson, S. Ondrejka, A. Nicolae, K. L. Grogg, C. Allmer, K. M. Ristow, W. H. Wilson, W. R. Macon, M. E. Law, J. R. Cerhan, T. M. Habermann, S. M. Ansell, A. Dogan, M. J. Maurer, A. L. Feldman, ALK-negative anaplastic large cell lymphoma is a genetically heterogeneous disease with widely disparate clinical outcomes, Blood, 2014, 124, 9, 1473

    CrossRef

  5. 5
    Kristen Ganjoo, Fangxin Hong, Sandra J. Horning, Randy D. Gascoyne, Yasodha Natkunam, Lode J. Swinnen, Thomas M. Habermann, Brad S. Kahl, Ranjana H. Advani, Bevacizumab and cyclosphosphamide, doxorubicin, vincristine and prednisone in combination for patients with peripheral T-cell or natural killer cell neoplasms: an Eastern Cooperative Oncology Group study (E2404), Leukemia & Lymphoma, 2014, 55, 4, 768

    CrossRef

  6. 6
    Irene Biasoli, Marina Cesaretti, Monica Bellei, Antonino Maiorana, Goretta Bonacorsi, Micol Quaresima, Massimiliano Salati, Massimo Federico, Stefano Luminari, Dismal outcome of t-cell lymphoma patients failing first-line treatment: results of a population-based study from the Modena Cancer Registry, Hematological Oncology, 2014, 32, 4
  7. 7
    Pier Paolo Piccaluga, Anna Gazzola, Claudia Mannu, Stefano A Pileri, Pier Luigi Zinzani, Past, present and future treatment strategies in peripheral T-cell lymphomas, International Journal of Hematologic Oncology, 2014, 3, 4, 299

    CrossRef

  8. 8
    Teresa Palomero, Lucile Couronné, Hossein Khiabanian, Mi-Yeon Kim, Alberto Ambesi-Impiombato, Arianne Perez-Garcia, Zachary Carpenter, Francesco Abate, Maddalena Allegretta, J Erika Haydu, Xiaoyu Jiang, Izidore S Lossos, Concha Nicolas, Milagros Balbin, Christian Bastard, Govind Bhagat, Miguel A Piris, Elias Campo, Olivier A Bernard, Raul Rabadan, Adolfo A Ferrando, Recurrent mutations in epigenetic regulators, RHOA and FYN kinase in peripheral T cell lymphomas, Nature Genetics, 2014, 46, 2, 166

    CrossRef

  9. 9
    Esther H.L. Chan, Suat-Jin Lu, Fredrik Petersson, Kong-Bing Tan, Wee-Joo Chng, Siok-Bian Ng, Unusual case of metachronous EBV-associated B-cell and NK/T-cell lymphoma mimicking polymyositis-diagnostic challenges and pitfalls, American Journal of Hematology, 2014, 89, 1
  10. 10
    Yamin Lai, Meifen Zhang, Li Wang, Aiming Yang, Jingnan Li, Xiao Zhang, Xiang Zhou, Tao Hong, Jiaming Qian, Dingrong Zhong, Uveitis and T cell lymphoma: a rare but notable relationship, Medical Oncology, 2014, 31, 8

    CrossRef

  11. 11
    Hee Jin So, Jin Kyung Lee, Young Jun Hong, Seok-Il Hong, Hye Jin Kang, Seung-Sook Lee, Yoon Hwan Chang, A Case of Hepatosplenic T-cell Lymphoma Diagnosed by Bone Marrow Examination, Laboratory Medicine Online, 2013, 3, 2, 104

    CrossRef

  12. 12
    Wenqing Qi, Catherine Spier, Xiaobing Liu, Amit Agarwal, Laurence S. Cooke, Daniel O. Persky, Deyu Chen, Thomas P. Miller, Daruka Mahadevan, Alisertib (MLN8237) an investigational agent suppresses Aurora A and B activity, inhibits proliferation, promotes endo-reduplication and induces apoptosis in T-NHL cell lines supporting its importance in PTCL treatment, Leukemia Research, 2013, 37, 4, 434

    CrossRef

  13. 13
    Hisao Nagoshi, Junya Kuroda, Tsutomu Kobayashi, Saori Maegawa, Yoshiaki Chinen, Miki Kiyota, Ryuko Nakayama, Shinsuke Mizutani, Yuji Shimura, Mio Yamamoto-Sugitani, Yosuke Matsumoto, Shigeo Horiike, Masafumi Taniwaki, Clinical manifestation of angioimmunoblastic T-cell lymphoma with exuberant plasmacytosis, International Journal of Hematology, 2013, 98, 3, 366

    CrossRef

  14. 14
    Jan-Henrik Mikesch, Mareike Kuhlmann, Angela Demant, Utz Krug, Gabriela B. Thoennissen, Eva Schmidt, Torsten Kessler, Christoph Schliemann, Michele Pohlen, Michael Mohr, Georg Evers, Gabriele Köhler, Johannes Wessling, Rolf Mesters, Carsten Müller-Tidow, Wolfgang E. Berdel, Nils H. Thoennissen, DexaBEAM versus ICE salvage regimen prior to autologous transplantation for relapsed or refractory aggressive peripheral T cell lymphoma: a retrospective evaluation of parallel patient cohorts of one center, Annals of Hematology, 2013, 92, 8, 1041

    CrossRef

  15. 15
    Alessia Bari, Tamar Tadmor, Stefano Sacchi, Luigi Marcheselli, Eliana Valentina Liardo, Samantha Pozzi, Stefano Luminari, Luca Baldini, Sandra Marmiroli, Massimo Federico, Aaron Polliack, Monocytosis has adverse prognostic significance and impacts survival in patients with T-cell lymphomas, Leukemia Research, 2013, 37, 6, 619

    CrossRef

  16. 16
    Masahiro Uni, Akihide Yoshimi, Fumihiko Nakamura, Yutaka Takazawa, Masashi Fukayama, Mineo Kurokawa, Successful allogeneic stem cell transplantation for Lennert lymphoma, Annals of Hematology, 2013, 92, 6, 859

    CrossRef

  17. 17
    Kathrin Warner, Nicole Weit, Giuliano Crispatzu, Joan Admirand, Dan Jones, Marco Herling, T-Cell Receptor Signaling in Peripheral T-Cell Lymphoma – A Review of Patterns of Alterations in a Central Growth Regulatory Pathway, Current Hematologic Malignancy Reports, 2013, 8, 3, 163

    CrossRef

  18. 18
    Saranya A Selvaraj, Elizabeth Chairez, Lisa M Wilson, Mark Lazarev, Eric B Bass, Susan Hutfless, Use of case reports and the Adverse Event Reporting System in systematic reviews: overcoming barriers to assess the link between Crohn’s disease medications and hepatosplenic T-cell lymphoma, Systematic Reviews, 2013, 2, 1, 53

    CrossRef

  19. 19
    Prashant Sharma, Shivani S. Shinde, Ronnie F. Luyun, Waxing and Waning Lymphadenopathy, The American Journal of Medicine, 2013, 126, 5, e3

    CrossRef

  20. 20
    Meghan Karuturi, Anas Younes, Non-Hodgkin Lymphomas: Advanced Diagnostics & Personalized Therapies, 2013,

    CrossRef

  21. 21
    Kein-Leong Yim, Sue Ashley, Assessment of gemcitabine, cisplatin and methylprednisolone (GEM-P) combination treatment for non-Hodgkin T cell lymphoma, Medical Oncology, 2012, 29, 5, 3535

    CrossRef

  22. 22
    Motoko Yamaguchi, Current and future management of NK/T-cell lymphoma based on clinical trials, International Journal of Hematology, 2012, 96, 5, 562

    CrossRef

  23. You have full text access to this Open Access content23
    Michela Boi, Anastasios Stathis, Emanuele Zucca, Giorgio Inghirami, Francesco Bertoni, Genetic alterations in systemic nodal and extranodal non-cutaneous lymphomas derived from mature T cells and natural killer cells, Cancer Science, 2012, 103, 8
  24. 24
    Michael Youngjun Choi, Mary Jo Lechowicz, Management of the Cutaneous Peripheral T-Cell Lymphomas, The Cancer Journal, 2012, 18, 5, 439

    CrossRef

  25. 25
    Neoplasms of Mature B, T and NK Cells,